In Vivo Efficacy of Anti-CD20-Interferon-Gamma Fusion Protein Against Syngeneic B Cell Lymphoma Is Mediated By Natural Killer Cells

被引：0
|
作者：
Vasuthasawat, Alex [1 ]
Yamada, Reiko E. [2 ]
Trinh, Kham R. [1 ]
Rokni, Neiki [2 ]
Morrison, Sherie L. [1 ]
Timmerman, John M. [2 ]
机构：
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-131890
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1575
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Genetically engineered natural killer (NK) cell immunotherapy for poor risk B-cell (CD20+) leukemia and lymphoma (L/L)
    Chu, Yaya
    Ayello, Janet
    Hochberg, Jessica
    Murphy, James
    Stier, Andrew
    Cairo, Mitchell S.
    CANCER RESEARCH, 2012, 72
  • [42] The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells
    Aguilar, Oscar A.
    Gonzalez-Hinojosa, Maria D. R.
    Arakawa-Hoyt, Janice S.
    Millan, Alberto J.
    Gotthardt, Dagmar
    Nabekura, Tsukasa
    Lanier, Lewis L.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2023, 113 (01) : 27 - 40
  • [43] The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells
    Aguilar, Oscar A.
    Gonzalez-Hinojosa, Maria D. R.
    Arakawa-Hoyt, Janice S.
    Millan, Alberto J.
    Gotthardt, Dagmar
    Nabekura, Tsukasa
    Lanier, Lewis L.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [44] Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasms
    Bagnara, Davide
    Ibatici, Adalberto
    Corselli, Mirko
    Sessarego, Nadia
    Tenca, Claudya
    De Santanna, Amleto
    Mazzarello, Andrea
    Daga, Antonio
    Corvo, Renzo
    De Rossi, Giulio
    Frassoni, Francesco
    Ciccone, Ermanno
    Fais, Franco
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (07): : 967 - 974
  • [45] Comparison of Lu-177-anti-CD20 (Rituximab) efficacy on human and canine B-cell lymphoma xenografts
    Balogh, L.
    Mikolajczak, R.
    Wojdowska, W.
    Mathe, D.
    Polyak, A.
    Postenyi, Z.
    Haasz, V.
    Janoki, G.
    Thuroczy, J.
    Joba, R. Peter
    Dabasi, G.
    Barra, M.
    Bus, K.
    Jorgov, L.
    Janoki, G. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S318 - S319
  • [46] Analysis of CD20-Mediated Signals in Refractory Diffuse Large B-Cell Lymphoma Cells.
    Nakamaki, Tsuyoshi
    Fukuchi, Kunihiko
    Nakashima, Hidetoshi
    Ariizumi, Hirotsugu
    Maeda, Takashi
    Saito, Bungo
    Yanagisawa, Kouji
    Tomoyasu, Shigeru
    BLOOD, 2012, 120 (21)
  • [47] Natural Killer (NK) cells successfully transduced with an anti-CD20 chimeric antigen receptor (CAR) by mRNA nucleofection have significant cytotoxicity against CD20+ non-Hodgkin's lymphoma (NHL)
    Chu, Y.
    Ayello, J.
    Hochberg, J.
    van de Ven, C.
    Katz, J.
    Lo, L.
    Cairo, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 66 - 66
  • [48] A role for Bcl-xL in CD1d-mediated Natural Killer T cell responses to B cells
    Subrahmanyam, Priyanka
    Webb, Tonya
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [49] Construction and Characterization of a Bispecific Anti-CD20 Antibody with Potent Antitumor Activity against B-Cell Lymphoma
    Li, Bohua
    Zhang, Xunming
    Shi, Shu
    Zhao, Lei
    Zhang, Dapeng
    Qian, Weizhu
    Zheng, Lei
    Gao, Jie
    Wang, Hao
    Guo, Yajun
    CANCER RESEARCH, 2010, 70 (15) : 6293 - 6302
  • [50] Lentiviral Transduction of Ex Vivo Expanded Natural Killer Cells with a CD19 Chimeric Antigen Receptor Induces Cytotoxicity against Resistant B Cell Malignancies
    Ramanathan, Muthalagu
    Su, Su
    Lundqvist, Andreas
    Berg, Maria
    Smith, Aleah
    Lopez, Rebecca
    Williams, Ann
    Bahceci, Erkut
    McCoy, J. Philip
    Boissel, Laurent
    Klingemann, Hans-Georg
    Childs, Richard
    BLOOD, 2008, 112 (11) : 1213 - 1213
12345